ES2164665T3 - Inhibidores de proteasas retrovirales. - Google Patents

Inhibidores de proteasas retrovirales.

Info

Publication number
ES2164665T3
ES2164665T3 ES93914694T ES93914694T ES2164665T3 ES 2164665 T3 ES2164665 T3 ES 2164665T3 ES 93914694 T ES93914694 T ES 93914694T ES 93914694 T ES93914694 T ES 93914694T ES 2164665 T3 ES2164665 T3 ES 2164665T3
Authority
ES
Spain
Prior art keywords
pct
inhibitors
retroviral proteases
sec
date
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES93914694T
Other languages
English (en)
Inventor
Bernd Stowasser
Jian-Qi Li
Anuschirwan Peyman
Karl-Heinz Budt
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Sanofi Aventis Deutschland GmbH
Original Assignee
Aventis Pharma Deutschland GmbH
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Aventis Pharma Deutschland GmbH filed Critical Aventis Pharma Deutschland GmbH
Application granted granted Critical
Publication of ES2164665T3 publication Critical patent/ES2164665T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02—Phosphorus compounds
    • C07F9/28—Phosphorus compounds with one or more P—C bonds
    • C07F9/30—Phosphinic acids [R2P(=O)(OH)]; Thiophosphinic acids ; [R2P(=X1)(X2H) (X1, X2 are each independently O, S or Se)]
    • C07F9/32—Esters thereof
    • C07F9/3205—Esters thereof the acid moiety containing a substituent or a structure which is considered as characteristic
    • C07F9/3211—Esters of acyclic saturated acids which can have further substituents on alkyl
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02—Phosphorus compounds
    • C07F9/28—Phosphorus compounds with one or more P—C bonds
    • C07F9/30—Phosphinic acids [R2P(=O)(OH)]; Thiophosphinic acids ; [R2P(=X1)(X2H) (X1, X2 are each independently O, S or Se)]
    • C07F9/32—Esters thereof
    • C07F9/3205—Esters thereof the acid moiety containing a substituent or a structure which is considered as characteristic
    • C07F9/3241—Esters of arylalkanephosphinic acids
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02—Phosphorus compounds
    • C07F9/28—Phosphorus compounds with one or more P—C bonds
    • C07F9/48—Phosphonous acids [RP(OH)2] including [RHP(=O)(OH)]; Thiophosphonous acids including [RP(SH)2], [RHP(=S)(SH)]; Derivatives thereof
    • C07F9/4808—Phosphonous acids [RP(OH)2] including [RHP(=O)(OH)]; Thiophosphonous acids including [RP(SH)2], [RHP(=S)(SH)]; Derivatives thereof the acid moiety containing a substituent or structure which is considered as characteristic
    • C07F9/4816—Acyclic saturated acids or derivatices which can have further substituents on alkyl
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/06—Dipeptides
    • C07K5/06191—Dipeptides containing heteroatoms different from O, S, or N
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Molecular Biology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biophysics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Other In-Based Heterocyclic Compounds (AREA)

Abstract

LA PRESENTE INVENCION SE REFIERE A UN COMPUESTO DE LA FORMULA (I) DONDE Q REPRESENTA UN RESTO DE LA FORMULA (IIA) O (IIB), Y ES OXIGENO O AZUFRE Y A, R2, R3, R4, R5, R6, R7, ASI COMO LOS RESTOS PROVISTOS CON EL CORRESPONDIENTE ASTERISCO SE DEFINEN COMO EN LA DESCRIPCION, UN PROCESO PARA SU ELABORACION, ASI COMO SU UTILIZACION PARA LA INHIBICION DE PROTEASAS RETROVIRALES.
ES93914694T 1992-06-24 1993-06-22 Inhibidores de proteasas retrovirales. Expired - Lifetime ES2164665T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE4220566A DE4220566A1 (de) 1992-06-24 1992-06-24 Inhibitoren retroviraler Proteasen

Publications (1)

Publication Number Publication Date
ES2164665T3 true ES2164665T3 (es) 2002-03-01

Family

ID=6461647

Family Applications (1)

Application Number Title Priority Date Filing Date
ES93914694T Expired - Lifetime ES2164665T3 (es) 1992-06-24 1993-06-22 Inhibidores de proteasas retrovirales.

Country Status (8)

Country Link
US (1) US5663139A (es)
EP (1) EP0649426B1 (es)
AT (1) ATE206127T1 (es)
DE (2) DE4220566A1 (es)
DK (1) DK0649426T3 (es)
ES (1) ES2164665T3 (es)
PT (1) PT649426E (es)
WO (1) WO1994000461A1 (es)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE102007032669A1 (de) 2007-07-13 2009-01-15 Clariant International Limited Alkylphosphonigsäuren, -salze und -ester, Verfahren zu deren Herstellung und ihre Verwendung

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0428849A3 (en) * 1989-09-28 1991-07-31 Hoechst Aktiengesellschaft Retroviral protease inhibitors
EP0435059B1 (de) * 1989-12-16 1997-11-05 Hoechst Aktiengesellschaft Inhibitoren retroviraler Proteasen

Also Published As

Publication number Publication date
WO1994000461A1 (de) 1994-01-06
US5663139A (en) 1997-09-02
PT649426E (pt) 2002-03-28
DE59310218D1 (de) 2001-10-31
EP0649426B1 (de) 2001-09-26
DE4220566A1 (de) 1994-01-20
DK0649426T3 (da) 2002-01-21
EP0649426A1 (de) 1995-04-26
ATE206127T1 (de) 2001-10-15

Similar Documents

Publication Publication Date Title
DK0810209T3 (da) Alpha - and beta-aminosyre-hydroxyethylaminosulfonamider til anvendelse som inhibitorer af retrovirale proteaser
DE69831937D1 (de) Bicyclische protein-farnesyl-transferase inhibitoren
GR3021404T3 (en) Nitric esters of derivatives of the 2-(2,6-di-halophenylamino)phenylacetic acid and process for their preparation.
IL115903A0 (en) Use of dioxomorpholines for combating endoparasites new dioxomorpholines and processes for their preparation
DK0696270T3 (da) 4-Aminofluorbenzamider og deres anvendelse som cytotoksiske promedikamenter
DE69433984D1 (de) Arylpiperazinderivate von indol als liganden der rezeptoren 5 ht1-like, 5 ht1b und 5 ht1d
DK0689534T3 (da) Amidderivater som 5-HT1A-ligander
DE69623610T2 (de) Neue heterozyklische chemie
ATE148345T1 (de) Therapeutische verwendung von phosphoryl-l-serin- n-acyl-sphingosin
MX9303605A (es) Derivados de azabicicloheptano n-substituidas, su obtencion y uso.
HU9301388D0 (en) Method for producing hydroxy-ethylene-isoster type compounds of hiv-protease inhibiting effect containing dithiolamine-glycine
ES2164665T3 (es) Inhibidores de proteasas retrovirales.
HUT73231A (en) Pharmaceutical compositions with 17-beta-monosubstituted-carbamoyl-4-aza-5-alpha-androst-1-en-3-ones for treatment of chronic prostatitis
DE69405760D1 (de) 4-aza-pregnan-5-alpha-reductase isozym 1 inhibitoren
CA2032303A1 (en) Inhibitors of retroviral proteases
PT100682A (pt) Agentes anti-helminticos derivados de benzimidazole e processo para a sua preparacao
KR960700223A (ko) C-치환 디에틸렌 트리아민의 제조 방법(Process for the Production of C-Substituted Diethylenetriamines)
FI955707A (fi) Indolijohdannaiset steroidi-5alfa-reduktaasin inhibiittoreina
DK0625972T3 (da) Fremgangsmåde til fremstilling af 2-amino-7-nitrobenzothiazoler
MD950234A (ro) Procedeu de obtinere a amidelor acidului 3,3-diarilacrilic
DK0850225T3 (da) Mellemprodukt til fremstilling af en farmaceutisk aktiv forbindelse

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 649426

Country of ref document: ES